Audrey Rico

2.1k total citations
49 papers, 1.2k citations indexed

About

Audrey Rico is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Audrey Rico has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pathology and Forensic Medicine, 22 papers in Neurology and 13 papers in Oncology. Recurrent topics in Audrey Rico's work include Multiple Sclerosis Research Studies (37 papers), Peripheral Neuropathies and Disorders (17 papers) and Polyomavirus and related diseases (11 papers). Audrey Rico is often cited by papers focused on Multiple Sclerosis Research Studies (37 papers), Peripheral Neuropathies and Disorders (17 papers) and Polyomavirus and related diseases (11 papers). Audrey Rico collaborates with scholars based in France, Germany and United States. Audrey Rico's co-authors include Bertrand Audoin, Jean Pelletier, Jean‐Philippe Ranjeva, Wafaa Zaaraoui, Sylviane Confort‐Gouny, Françoise Reuter, Adil Maarouf, Irina Malikova, Elisabeth Soulier and Clémence Boutière and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Audrey Rico

49 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Audrey Rico France 20 825 419 278 174 155 49 1.2k
Zhaleh Khaleeli United Kingdom 19 892 1.1× 277 0.7× 302 1.1× 271 1.6× 81 0.5× 27 1.1k
Channa Kolb United States 21 807 1.0× 301 0.7× 159 0.6× 199 1.1× 123 0.8× 50 1.2k
Céline Louapre France 18 949 1.2× 506 1.2× 158 0.6× 109 0.6× 178 1.1× 67 1.4k
Emmanuel Boulay United Kingdom 13 909 1.1× 457 1.1× 345 1.2× 271 1.6× 161 1.0× 27 1.5k
Morten Blinkenberg Denmark 23 1.0k 1.2× 572 1.4× 449 1.6× 212 1.2× 223 1.4× 65 1.8k
Aaron Boster United States 22 925 1.1× 405 1.0× 168 0.6× 207 1.2× 104 0.7× 44 1.4k
María Jesús Arévalo Spain 15 1.1k 1.3× 384 0.9× 144 0.5× 266 1.5× 127 0.8× 20 1.2k
Peter Brex United Kingdom 14 1.1k 1.4× 550 1.3× 205 0.7× 349 2.0× 62 0.4× 27 1.4k
Jan‐Patrick Stellmann Germany 18 579 0.7× 232 0.6× 172 0.6× 107 0.6× 74 0.5× 49 1.1k
DH Miller United Kingdom 14 939 1.1× 445 1.1× 198 0.7× 322 1.9× 76 0.5× 16 1.4k

Countries citing papers authored by Audrey Rico

Since Specialization
Citations

This map shows the geographic impact of Audrey Rico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey Rico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey Rico more than expected).

Fields of papers citing papers by Audrey Rico

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audrey Rico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey Rico. The network helps show where Audrey Rico may publish in the future.

Co-authorship network of co-authors of Audrey Rico

This figure shows the co-authorship network connecting the top 25 collaborators of Audrey Rico. A scholar is included among the top collaborators of Audrey Rico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audrey Rico. Audrey Rico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stellmann, Jan‐Patrick, Clémence Boutière, Audrey Rico, et al.. (2025). Extended-interval dosing of rituximab/ocrelizumab is associated with a reduced decrease in IgG levels in multiple sclerosis. Neurotherapeutics. 22(3). e00554–e00554. 2 indexed citations
2.
Boutière, Clémence, Audrey Rico, Jan‐Patrick Stellmann, et al.. (2025). Fluorescein Angiography as a Surrogate Marker of Disease Activity in Susac Syndrome. Neurology Neuroimmunology & Neuroinflammation. 12(2). e200379–e200379. 1 indexed citations
3.
Boutière, Clémence, Audrey Rico, Jan‐Patrick Stellmann, et al.. (2025). Diagnostic Utility of Kappa Free Light Chain Index in Adults With Inaugural Optic Neuritis. Neurology Neuroimmunology & Neuroinflammation. 12(3). e200386–e200386. 1 indexed citations
4.
Lépine, Anne, Adil Maarouf, Damien Biotti, et al.. (2024). Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis. Multiple Sclerosis Journal. 30(2). 261–265. 9 indexed citations
5.
Maarouf, Adil, Audrey Rico, Clémence Boutière, et al.. (2024). Active and non-active progression independent of relapse activity within the first 20 years of relapsing multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 95(10). jnnp–2024. 1 indexed citations
6.
Zaaraoui, Wafaa, Clémence Boutière, Audrey Rico, et al.. (2024). Cortical Lesions as an Early Hallmark of Multiple Sclerosis: Visualization by 7 T MRI. Investigative Radiology. 59(11). 747–753. 4 indexed citations
7.
Maarouf, Adil, Clémence Boutière, Audrey Rico, et al.. (2024). Factors affecting the topography of nitrous oxide‐induced neurological complications. European Journal of Neurology. 31(7). e16291–e16291. 3 indexed citations
8.
Boutière, Clémence, Audrey Rico, Frédéric Vely, et al.. (2024). Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 11(3). e200231–e200231. 2 indexed citations
9.
Joubert, Bastien, Marie Bénaiteau, Clémence Boutière, et al.. (2024). Anti-IgLON5 Disease With Inaugural Bilateral Neuropapillitis. Neurology. 102(8). e209284–e209284. 1 indexed citations
10.
Maarouf, Adil, et al.. (2023). Disease Evolution in Women With Highly Active MS Who Suspended Natalizumab During Pregnancy vs Rituximab/Ocrelizumab Before Conception. Neurology Neuroimmunology & Neuroinflammation. 10(5). 5 indexed citations
11.
Rico, Audrey, Clémence Boutière, Frédéric Vely, et al.. (2023). Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 10(5). 22 indexed citations
12.
Rico, Audrey, Läétitia Ninove, Adil Maarouf, et al.. (2021). Determining the best window for BNT162b2 mRNA vaccination for SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20 therapy. Multiple Sclerosis Journal - Experimental Translational and Clinical. 7(4). 3080425342–3080425342. 5 indexed citations
13.
Maarouf, Adil, Clémence Boutière, Audrey Rico, Bertrand Audoin, & Jean Pelletier. (2018). How much progress has there been in the second-line treatment of multiple sclerosis: A 2017 update. Revue Neurologique. 174(6). 429–440. 6 indexed citations
14.
Reuter, Françoise, Wafaa Zaaraoui, Arnaud Le Troter, et al.. (2017). New brain lesions with no impact on physical disability can impact cognition in early multiple sclerosis: A ten-year longitudinal study. PLoS ONE. 12(11). e0184650–e0184650. 19 indexed citations
15.
Cohen, Mikaël, Gustavo Adolfo Sierra Romero, J. A. Bas, et al.. (2017). Monitoring CD27 + memory B-cells in neuromyelitis optica spectrum disorders patients treated with rituximab: Results from a bicentric study. Journal of the Neurological Sciences. 373. 335–338. 55 indexed citations
16.
Rico, Audrey, Wafaa Zaaraoui, J. Franques, et al.. (2010). Motor cortical reorganization is present after a single attack of multiple sclerosis devoid of cortico-spinal dysfunction. Magnetic Resonance Materials in Physics Biology and Medicine. 24(2). 77–84. 11 indexed citations
17.
Audoin, Bertrand, Wafaa Zaaraoui, Françoise Reuter, et al.. (2010). Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 81(6). 690–695. 130 indexed citations
18.
Reuter, Françoise, Bertrand Audoin, Audrey Rico, et al.. (2009). Les troubles cognitifs. Revue Neurologique. 165. S113–S122. 3 indexed citations
19.
Feuillet, L., Jean Pelletier, Laurent Suchet, et al.. (2007). Prospective clinical and electrophysiological follow-up on a multiple sclerosis population treated with interferon beta-1 a. Multiple Sclerosis Journal. 13(3). 348–356. 17 indexed citations
20.
Balaguer, Mònica, et al.. (2007). Taquicardia paroxística supraventricular en el niño y el lactante. Anales de Pediatría. 67(2). 133–138. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhaleh Khaleeli Breakdown of academic impact, for papers by Channa Kolb Breakdown of academic impact, for papers by Céline Louapre Breakdown of academic impact, for papers by Emmanuel Boulay Breakdown of academic impact, for papers by Morten Blinkenberg Breakdown of academic impact, for papers by Aaron Boster Breakdown of academic impact, for papers by María Jesús Arévalo Breakdown of academic impact, for papers by Peter Brex Breakdown of academic impact, for papers by Jan‐Patrick Stellmann Breakdown of academic impact, for papers by DH Miller
Rankless by CCL
2026